RASSF6 and colorectal carcinoma: For example, in melanoma, RASSF6 suppresses MAPK activation [17]; whether RASSF6 also inhibits MAPK signalling in CRC, and whether Wnt is the primary mechanism that mediates the regulation of RASSF6 in CRC remains to be determined.